NID1 / Entactin / Nidogen Antibody (aa219-268)
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IHC-P, E |
---|---|
Primary Accession | P14543 |
Other Accession | 4811 |
Reactivity | Human, Mouse, Rat |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | IgG |
Calculated MW | 136377 Da |
Dilution | ELISA (1:20000), IHC-P (20 µg/ml), WB (1:500 - 1:1000), |
Gene ID | 4811 |
---|---|
Other Names | NID1, Enactin, Nidogen 1, NID, Nidogen, Entactin, NID-1, Nidogen (enactin), Nidogen-1 |
Target/Specificity | NID1 Antibody detects endogenous levels of total NID1 protein. |
Reconstitution & Storage | PBS (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02% sodium azide, 50% glycerol. Store at -20°C for up to one year. |
Precautions | NID1 / Entactin / Nidogen Antibody (aa219-268) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | NID1 |
---|---|
Synonyms | NID |
Function | Sulfated glycoprotein widely distributed in basement membranes and tightly associated with laminin. Also binds to collagen IV and perlecan. It probably has a role in cell-extracellular matrix interactions. |
Cellular Location | Secreted, extracellular space, extracellular matrix, basement membrane |
Volume | 50 µl |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Sulfated glycoprotein widely distributed in basement membranes and tightly associated with laminin. Also binds to collagen IV and perlecan. It probably has a role in cell- extracellular matrix interactions.
References
Nagayoshi T.,et al.DNA 8:581-594(1989).
Zimmermann K.,et al.Genomics 27:245-250(1995).
Gregory S.G.,et al.Nature 441:315-321(2006).
Fazio M.J.,et al.J. Invest. Dermatol. 97:281-285(1991).
Totoki Y.,et al.Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.